NEI Research News

New York University researchers have discovered new cell types in the visual system of flies, made possible by their creation of a tool that finds and labels neurons during development.

Missouri S&T researchers have developed a treatment that could eventually enable glaucoma patients to only use eye drops once per week instead of daily, and it should also be more effective.

Designed by researchers at NYU, Commute Booster routes public-transportation users through the “middle mile” — the part of a journey inside subway stations or other similar transit hubs.

SUNY College of Optometry’s Dr. Alexandra Benavente-Pérez was awarded a grant that will explore the unknown nature of the relationship between myopia (nearsightedness) and glaucoma by focusing on their effect on the ganglion cell complex.

Cedars-Sinai researchers uncover disease-related changes to the cornea and propose potential therapeutic approaches to correct diabetic wound healing.

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years

A new study suggests that eye drops developed by Columbia University researchers could be a more effective–and comfortable–therapy for a common eye disease currently treated with injections into the eye.

A Northwestern Medicine study has uncovered novel cellular mechanisms within the retina, findings that could help advance the development of targeted therapeutics for diseases and conditions affecting vision.

Three-dimensional, lab-grown “mini-corneas” resemble the developing human cornea, making them a powerful new tool for the study of corneal diseases, a study finds.

Scientists find association between lipid metabolism and glaucoma.